$ARTL· SEC filing ·

ARTL Reports $2.8B Total Assets, $3.0B Liabilities, Going Concern Doubt, FY2025 Net Loss $X, FY2024 Net Loss $Y, Auditor MaloneBailey Since 2015

Artelo Biosciences, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $1.43

Post-detection moves

1h
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS